CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Immune response in COVID-19: what is next?

Biology, Free Full-Text

Smoking and SARS-CoV-2 Impair Dendritic Cells and Regulate DC-SIGN Expression in Tissues

IJMS, Free Full-Text

Proteomic landscape of SARS-CoV-2– and MERS-CoV–infected primary human renal epithelial cells

The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies: Molecular Therapy

Host genetic factors determining COVID-19 susceptibility and severity - eBioMedicine

Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission - ScienceDirect

Frontiers Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease

SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight

Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells

Human cell receptors: potential drug targets to combat COVID-19

Cells, Free Full-Text